Prof. Yilong Wang is a neurologist serving patients with cerebral small vessel diseases (cSVD), stroke, cerebral aneurysms and vascular malformations in Beijing Tiantan Hospital. Dr. Wang’s research focuses on using clinical research methodology to address both clinical and pathogenetic questions of cSVD and ischemic stroke. Over the years, Dr. Wang has contributed to research that has quantified stroke burden in China, identified traditional and recent risk factors related to stroke; verified therapeutic approaches including efficacy and safety of combined use of clopidogrel and aspirin in high-risk TIA and minor ischemic stroke; studied quality improvement for acute ischemic stroke care; as well as explored targeted genetics of stroke. Some studies have changed guidelines for how to treat patients with stroke all over the world. Dr. Wang has published more than 200 scientific articles in journals with high impact factor, including New Engl J Med, The Lancet, JAMA, BMJ, Circulation, and JAMA Neurology.